MedTrace Logo

The Effectiveness of Using a Palliative Care QPL on the Selfefficacy and Preparedness of Indonesian Homecare Workers

NCT06847828 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-02-26

No results posted yet for this study

Summary

Foreign studies on caregivers' use of QPL in end-of-life care, decision-making, and satisfaction are mostly conducted with family members who share the same language. Foreign family caregivers are a local cultural feature of Taiwan. This study explores the role of foreign family caregivers in end-of-life care in Taiwan. Cultural issues and differences, whether the number of questions asked, care readiness and self-efficacy can be increased after the intervention of the end-of-life care QPL, and the use of QPL that is appropriate for Indonesian culture to communicate and prepare for end-of-life care in hospice home care, is expected to provide A reference for communication between medical teams and foreign home caregivers and improvement of care quality.

Conditions

  • Question Prompt List
  • Caregivers
  • End-of-life Care

Interventions

OTHER

QPL

The QPL is in the form of a structured list of questions that caregivers would like to ask. It includes 17 questions on concept communication and 20 questions on end-of-life care. You can check the questions you want to ask and then discuss them with the medical team.

Sponsors & Collaborators

  • Den,Yu-Yun

    lead OTHER

Principal Investigators

  • Chuan Mei Chang · Ph.D

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-31
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06847828 on ClinicalTrials.gov